Bayer to Pay $40 Million to Resolve Allegations about Marketing of Three Drugs
Bayer Corporation and related entities have agreed to pay $40 million to resolve FCA allegations in connection with the drugs Trasylol, Avelox, and Baycol.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.